Author

Hadar Edelman-Klapper

DECREASED IMMUNE RESPONSE TO COVID-19 MRNA VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES TREATED WITH ANTI TNF?: A PROSPECTIVE, CONTROLLED, MULTI-CENTER ISRAELI STUDY
DECREASED IMMUNE RESPONSE TO COVID-19 MRNA VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES TREATED WITH ANTI TNF?: A PROSPECTIVE, CONTROLLED, MULTI-CENTER ISRAELI STUDY

Hadar Edelman-Klapper  et al.

SEROLOGIC RESPONSE AND SAFETY AFTER THIRD DOSE OF THE COVID-19 BNT162B2 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
SEROLOGIC RESPONSE AND SAFETY AFTER THIRD DOSE OF THE COVID-19 BNT162B2 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

Hadar Edelman-Klapper  et al.

DECREASED IMMUNE RESPONSE TO COVID-19 MRNA VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES TREATED WITH ANTI TNF?: A PROSPECTIVE, CONTROLLED, MULTI-CENTER ISRAELI STUDY
DECREASED IMMUNE RESPONSE TO COVID-19 MRNA VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES TREATED WITH ANTI TNF?: A PROSPECTIVE, CONTROLLED, MULTI-CENTER ISRAELI STUDY

Item 1 - 3 / 3
1